ADAP
Adaptimmune Therapeutics
ADAP
ADAP
69 hedge funds and large institutions have $166M invested in Adaptimmune Therapeutics in 2022 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 13 closing their positions.
Holders
69
Holders Change
+1
Holders Change %
+1.47%
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
16
Reduced
23
Closed
13
Calls
$81K
Puts
$4K
Net Calls
+$77K
Net Calls Change
+$1K